Clinical & Translational Oncology Journal Citation Rate 2026
1699-048X
eISSN 1699-3055
Springer Science+Business Media
ES
Q2 Quartile Established Impact
About Clinical & Translational Oncology
Clinical & Translational Oncology (CTO) is a peer-reviewed academic journal covering Breast Cancer Treatment Studies and Cancer Immunotherapy and Biomarkers, published by Springer Science+Business Media in ES, catalogued under ISSN 1699-048X (e-ISSN 1699-3055). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.27 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4290 USD).
Clinical & Translational Oncology Citation Rate 2026 — In Context
Clinical & Translational Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 2.27, placing it in the Q2 quartile within the Breast Cancer Treatment Studies research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Clinical & Translational Oncology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Clinical & Translational Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Clinical & Translational Oncology against similar journals in the field, use our journal comparison tool.
Submission Tips for Clinical & Translational Oncology
- Budget $4290 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Clinical & Translational … Compares
Compared against 22 journals in the same research areas.
| ISSN (Print) | 1699-048X |
|---|---|
| ISSN (Online) | 1699-3055 |
| Publisher | Springer Science+Business Media |
| Country | Spain |
| APC / Cost | $4290 USD |
In-depth profile & metrics
Clinical & Translational Oncology is published by Springer Science+Business Media and based in Spain. It runs on a subscription or hybrid model with an article-processing charge of USD 4290.
In our subject taxonomy, Clinical & Translational Oncology is classified under Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies and Lung Cancer Diagnosis and Treatment.
Clinical & Translational Oncology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 2.266.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Clinical & Translational Oncology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 2.266 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Clinical & Translational Onco… against similar publications in its field:
Related Journals in Your Field
-
Journal for ImmunoTherapy of Cancer BMJ IF 7.57
-
Cancer Immunology Immunotherapy Springer Science+Business Media IF 4.62
-
Critical Reviews in Oncology/Hematology Elsevier BV IF 4.62
-
Breast Cancer Research BioMed Central IF 4.57
-
BMJ Oncology BMJ IF 4.52
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S179824187
Get weekly updates for Breast Cancer Treatment Studies journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.